Physician – Internal Medicine, Medical Oncology Physician/faculty (Open Rank/Track Faculty)…ASCO AD

Screen reader users may encounter difficulty with this site. For assistance with applying, please contact hr-accessibleapplication@osu.edu. If you have questions while submitting an application, please review these frequently asked questions.

Current Employees and Students:

If you are currently employed or enrolled as a student at The Ohio State University, please log in to Workday to use the internal application process.

Welcome to The Ohio State University's career site.  We invite you to apply to positions of interest. In order to ensure your application is complete, you must complete the following:

• Ensure you have all necessary documents available when starting the application process. You can review the additional job description section on postings for documents that may be required.

• Prior to submitting your application, please review and update (if necessary) the information in your candidate profile as it will transfer to your application. 

Job Title:

Physician – Internal Medicine, Medical Oncology Physician/faculty (Open Rank/Track Faculty)…ASCO AD

Department:

The Ohio State University College of Medicine and the Wexner Medical Center seek Medical Oncologists to join the Department of Internal Medicine, Division of Medical Oncology. Academic rank and track commensurate with academic record and experience.

Positions we are actively recruiting for:
     *Breast Medical Oncologist
     *Gastrointestinal Medical Oncologist
     *Genitourinary Medical Oncologist
     *Neuroendocrine Medical Oncologist
     *Cutaneous Medical Oncologist
     *Head & Neck Medical Oncologist
     *Sarcoma Medical Oncologist
     *Phase-1 Focused
     *Inpatient Only (Medical Oncologist Hospitalist)
 

Division Overview

The Division of Medical Oncology’s mission is to provide cutting-edge, compassionate care to those suffering from solid tumor malignancies through Team Science. Team Science is a philosophical approach that integrates scientific discoveries into the care given to patients. As a national leader, we bring 21st century innovative therapies, including cell therapy, molecular diagnostic and therapeutic approaches, and immunotherapy advances to our cancer patients. Because there are no routine cancers, all our clinicians are subspecialized. We work in tumor-specific multidisciplinary teams with surgical, radiation and subspecialty departments to determine the optimal care and to offer participation to the most promising clinical trials.

The care we provide is highly coordinated through our subspecialty clinics at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James). The Division of Medical Oncology translates the newest cancer research findings by clinical and basic scientists working together to transform patient care and offer realistic hope for cures. Participation in clinical trials at the OSUCCC-James has led to multiple FDA- approved new standards of care for the treatment of various cancers. 

Our Cancer Center

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute expanded in December 2014 to become the 3rd largest cancer hospital in the U.S.  The extraordinary success of this new 398-bed state-of-the-art hospital has resulted in remarkable clinical growth and has created several opportunities for medical oncologists across the spectrum of solid tumor subspecialties.

Features include:

• NCI-designated Comprehensive Cancer Center since 1976
• One of only 11 freestanding cancer hospitals in the U.S.
• Magnet® designation
• One of only four cancer centers funded by the NCI to conduct Phase I and II cancer clinical trials
• Founding member of the National Comprehensive Cancer Network (NCCN)
• Founding member of the Oncology Research Information Exchange Network (ORIEN)
• Robust clinical trials program with active translational therapeutics that include a clinical research unit, Phase 1 U01 grant and N01 Phase II contract
• Consistently ranked as one of America’s Best Cancer Hospitals by U.S. News & World Report
• Fina